VERSANT VENTURE CAPITAL VI, L.P. sold 79.0% of their position (788K shares) of TEMPEST THERAPEUTICS, INC. on the open market
Open‑market sale worth $967.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/12/2024ACC: 0000950170-24-095675
10% Owner
Since Jun 2021
-788K
Net shares
Net seller
$967.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
788K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−400K
Price / share
$1.35
Trade value
$540.04K
% of position
40.1%
8/8/2024
997.94K→597.94K
Common Stock
Direct
Shares
−388K
Price / share
$1.10
Trade value
$426.99K
% of position
64.9%
8/12/2024
597.94K→209.94K
Total
Net shares
−788K
Net value
-$967.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/8/2024 | S · Sale | −400K | $1.35 | $540.04K | 40.1% | 997.94K | 597.94K |
| Common Stock Direct | 8/12/2024 | S · Sale | −388K | $1.10 | $426.99K | 64.9% | 597.94K | 209.94K |
| Total | −788K | -$967.03K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned2.12M
Common Stock
IndirectShares owned7.38K
Common Stock
IndirectShares owned1.17M
Total
3.30M indirect3.30M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.12M | Indirect |
| Common Stock | 7.38K | Indirect |
| Common Stock | 1.17M | Indirect |
| Total | 3.30M | 3.30M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported